COMPLEXE CRANBERRY
Food supplement declared in France, declaration No 2018-2-103
COMPLEXE CRANBERRY is a food supplement declared in France. Status: retiré du marché le 31 May 2021. 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- not provided
- Food business operator placing the product on the market
- Biofarma France (Sérent - Laboratoire Pierre Caron)
- Status
- Retiré du marché le 31 May 2021
- Form
- Gélule
- Daily dose
- 2 gélules par jour
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Insuffisance rénale, Utilisation prolongée
Declaration 153187, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Information
Retiré du marché le 31 May 2021, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium macrocarpon Aiton | Fruit | Autre extrait sec | 360 mg |
| Erica cinerea L. | Sommités fleuries | Extrait sec aqueux | 100 mg |
| Arctostaphylos uva-ursi (L.) Spreng. | Feuille | Extrait sec aqueux | 100 mg |
| Coriandrum sativum L. | Fruit | Poudre (de plantes séchées ou broyées) | 100 mg |
Additives
E470b, E551, E171
Other ingredients
Gélule végétale
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Déconseillé chez les enfants, les adolescents, les femmes enceintes et allaitantes, ainsi que chez les personnes souffrant d'insuffisance rénale ; ne pas dépasser une semaine d'utilisation.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.